Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
04 avr. 2023 15h53 HE
|
Nox Health
ALPHARETTA, Ga., April 04, 2023 (GLOBE NEWSWIRE) -- The United States Patent Office recently granted Nox Medical a new patent for methods supporting accurate diagnoses of sleep apnea, which are...
Neonatal Respiratory Distress Syndrome Treatment Market to Surpass USD 1.6 Bn by 2031, Latest Study by TMR
15 mars 2023 10h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 15, 2023 (GLOBE NEWSWIRE) -- The neonatal respiratory distress syndrome treatment market size was valued at US$ 780.1 Mn in 2022 and is expected to reach...
29 Organizations Achieve Excellence in Respiratory Care
16 févr. 2023 16h00 HE
|
American Association for Respiratory Care - Irving, TX
Irving, Feb. 16, 2023 (GLOBE NEWSWIRE) -- The American Association for Respiratory Care (AARC) has named 29 organizations from across the U.S. as recipients of the 2023-2024 Apex Recognition Award....
US Med-Equip partners with Turn Medical to help hospitals gain on-demand access to new automated prone therapy bed for critically ill respiratory patients
24 janv. 2023 08h01 HE
|
US Med-Equip
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- As healthcare professionals continue to battle COVID, the flu, and other respiratory illnesses, hospitals nationwide are gaining on-demand access to...
Global Digital Therapeutics Market Projected to Surpass $12,695.60 Million, Growing at 20.0% CAGR in the 2021–2028 Timeframe [175-Pages] | Reasoning by Research Dive
02 janv. 2023 09h01 HE
|
Research Dive
New York, USA, Jan. 02, 2023 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global digital therapeutics market. As per the report, the market is projected to hit $12,695.60...
Global Anesthesia and Respiratory Devices Market will reach to USD 74 billion by 2029 : GreyViews
22 déc. 2022 12h00 HE
|
GreyViews
Pune India, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Extracorporeal Membrane Oxygenation Market to hit USD 639 Million by 2032, says Global Market Insights Inc.
12 déc. 2022 06h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The extracorporeal membrane oxygenation market value is set to reach USD 639 million by 2032, according to a new research report by Global...
爱科百发宣布呼吸道合胞病毒新药爱司韦®的上市许可申请获国家药品监督管理局正式受理并纳入优先审评审批程序
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中国上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海爱科百发生物医药技术股份有限公司(以下简称“ 爱科百发”),一家致力于儿科及呼吸疾病领域创新药研发的生物制药企业,今日宣布中国国家药品监督管理局正式受理治疗呼吸道合胞病毒(RSV)感染新药爱司韦®(通用名:齐瑞索韦/ziresovir)的上市许可申请(NDA),并且纳入“优先审评审批”程序。 ...
愛科百發宣佈呼吸道合胞病毒新藥愛司韋®的上市許可申請獲國家藥品監督管理局正式受理並納入優先審評審批程式
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中國上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海愛科百發生物醫藥技術股份有限公司(以下簡稱“ 愛科百發”),一家致力於兒科及呼吸疾病領域創新藥研發的生物製藥企業,今日宣佈中國國家藥品監督管理局正式受理治療呼吸道合胞病毒(RSV)感染新藥愛司韋®(通用名:齊瑞索韋/ziresovir)的上市許可申請(NDA),並且納入“優先審評審批”程式。 ...
Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for Ziresovir for Treatment of RSV Infection
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical), a biopharma company dedicated to the discovery and development of drugs for...